Sustained Expansion and Transgene Expression of Coagulation Factor VIII-Transduced Cord Blood-Derived Endothelial Progenitor Cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 12, 2003, Pages 2266-2272

  Herder, Christian ^a,b   Tonn, Torsten ^a,d   Oostendorp, Robert ^c   Becker, Sven ^a   Keller, Ulrich ^c   Peschel, Christian ^c   Grez, Manuel ^b   Seifried, Erhard ^a  

^a Inst Transfus Med I   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Inst Transfus Med/Immunohematol   (Germany)

Author keywords

Cord blood; Endothelial progenitor cells; Factor VIII; Hemophilia; Lentiviral gene therapy

Indexed keywords

CD34 ANTIGEN; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ARTICLE; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CONTROLLED STUDY; CORD BLOOD DERIVED ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HEMOPHILIA A; HUMAN; HUMAN CELL; LENTIVIRINAE; NEWBORN; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENE; UMBILICAL CORD BLOOD; VASCULAR ENDOTHELIUM; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANTIGENS, CD34; BLOOD COAGULATION; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELLS, CULTURED; CULTURE MEDIA; ENDOTHELIUM, VASCULAR; FACTOR VIII; FETAL BLOOD; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELLS; HEMOPHILIA A; HUMANS; LENTIVIRUS; LUMINESCENT PROTEINS; PHENOTYPE; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 0346622393     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000100403.78731.9F     Document Type: Article

References (34)

1. Mannucci PM, Tuddenham EGD. The hemophilias: from royal genes to gene therapy. N Engl J Med. 2001;344:1773-1779.
2. Mannucci PM, Giangrande PLF. Choice of replacement therapy for hemophilia: recombinant products only? Hematol J. 2001;1:72-76.
3. Ragni MV. Safe passage: a plea for safety in hemophilia gene therapy. Mol Ther. 2002;6:436-440.
4. Wion KL, Kelly D, Summerfield JA, Tuddenham EG, Lawn RM. Distribution of FVIII mRNA and antigen in human liver and other tissues. Nature. 1985;317:726-729.
5. Zelechowska MG, van Mourik JA, Brodniewicz-Proba T. Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature. 1985;317:729-730.
6. Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells. J Biol Chem. 1999;274:19587-19592.
7. Hollestelle MJ, Thinnes T, Crain K, Stiko A, Kruijt JK, van Berkel TJC, Loskutoff DJ, van Mourik JA. Tissue distribution of FVIII gene expression in vivo: a closer look. Thromb Haemost. 2001;86:855-861.
8. VandenDriessche T, Collen D, Chuah MKL. Viral vector-mediated gene therapy for hemophilia. Curr Gene Ther. 2001;1:301-315.
9. Kelley K, Verma I, Pierce GF. Gene therapy: reality or myth for the global bleeding disorders community? Haemophilia. 2002;8:261-267.
10. Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 1996;3:137-144.
11. Lozier JN, Metzger ME, Donahue RE, Morgan RA. Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity. Blood. 1999;94:3968-3975.
12. Roth DA, Tawa NE Jr, O'Brien JM, Treco DA, Selden RF. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia. N Engl J Med. 2001;344:1735-1742.
13. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, Imaizumi T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest. 2000;105:1527-1536.
14. + lymphatic/vascular endothelial precursor cells. Blood. 2003;101:168-172.
15. Burger PE, Coetzee S, McKeehan WL, Kan M, Cook P, Fan Y, Suda T, Hebbel RP, Novitzky N, Muller WA, Wilson EL. Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood. 2002;100:3527-3535.
16. + cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion. Stem Cells. 2003;21:228-235.
17. Eggermann J, Kliche S, Jarmy G, Hoffmann K, Mayr-Beyrle U, Debatin KM, Waltenberger J, Beltinger C. Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res. 2003;58:478-486.
18. Saenko EL, Ananyeva NM, Moayeri M, Ramezani A, Hawley RG. Development of improved factor VIII molecules and new gene transfer approaches for hemophilia A. Curr Gene Ther. 2003;3:27-41.
19. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702-712.
20. Lin Y, Chang L, Solovey A, Healey JF, Lollar P, Hebbel RP. Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. Blood. 2002;99:457-462.
21. Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C, Grez M, Thrasher AJ. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther. 2002;13:803-813.
22. Tonn T, Herder C, Becker S, Seifried E, Grez M. Generation and characterization of human hematopoietic cell lines expressing factor VIII. J Hematother Stem Cell Res. 2002;11:695-704.
23. Zennou V, Petit C, Guetard D, Nehrbass U, Montagnier L, Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell. 2000;101:173-185.
24. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol. 1997;15:871-875.
25. Follenzi A, Naldini L. Generation of HIV-1 derived lentiviral vectors. Methods Enzymol. 2002;346:454-465.
26. Andrews JL, Weaver L, Kaleko M, Connelly S. Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes. Haemophilia. 1999;5:160-168.
27. Chuah MKL, VandenDriessche T, Morgan RA. Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A. Hum Gene Ther. 1995;6:1363-1377.
28. Schröder ARW, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110:521-529.
29. Garcia-Martin C, Chuah MKL, van Damme A, Robinson KE, Vanzieleghem B, Saint-Remy JM, Gallardo D, Ofosu FA, VandenDriessche T, Hortelano G. Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: potential for gene therapy of hemophilia A. J Gene Med. 2002;4:215-223.
30. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967.
31. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majewsky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107:1395-1402.
32. Grant MB, May WS, Caballero S, Brown GAJ, Guthrie SM, Mames RN, Byrne BJ, Vaught T, Spoerri PE, Peck AB, Scott EW. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 2002;6:607-612.
33. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, Asahara T. Endothelial progenitor cell VEGF gene transfer for vascular regeneration. Circulation. 2002;105:732-738.
34. Ferrari N, Glod J, Lee J, Kobiler D, Fine HA. Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors. Gene Ther. 2003;10:647-656.